Investing Profile

Mark Krul

InvestorVCFounder
Founder and Director at Aglaia Oncology Funds
Photo of Mark Krul, Aglaia Oncology Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Utrecht University Network
26 CONNECTIONS
cb
$100K - $5.0M
$1.5M
4
CompanyStageDateRound SizeTotal Raised
Inthera Bioscience
Series AJun 2018$5M
Series AMay 2017$11M
SeedDec 2015$4M
$20M
Co-investors: Nanna Luneborg (Forbion), Jasper Bos (Forbion), Keno Gutierrez (BGV (BioGeneration Ventures))
Cristal Therapeutics
Series UnknownJan 2017$14M
$14M
Research Manager HotmailPresent
Manager drug development HotmailPresent
Director Aglaia Oncology FundsPresent
Chairman Advisory Board ISA PharmaceuticalsPresent
Board Member HotmailPresent
Board Member Cristal TherapeuticsPresent
Board Member MIMETASPresent
Board Member Inthera Bioscience AGPresent
Chief Scientific Officer Oncode AcceleratorPresent
Strategic Advisor Immunogenik, Inc.Present
Founder and Director Aglaia Oncology FundsPresent
Chief Executive Officer Inthera Bioscience AGPresent
Universiteit Utrecht Ph.D. Medical biology
Utrecht University Ph.D. Medical biology